1h Free Analyst Time
The publisher has been monitoring the coronavirus test kits market in APAC and it is poised to decline by $2.48 bn during 2021-2025, progressing at a CAGR of over -17% during the forecast period. The report on coronavirus test kits market in APAC provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current APAC market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of coronavirus and new product launches. In addition, the increasing incidence of coronavirus is anticipated to boost the growth of the market as well.
The coronavirus test kits market in APAC analysis includes end-user segment and geographic landscape.
The coronavirus test kits market in APAC is segmented as below:
By End-user
- Government
- Non-government
By Geography
- India
- China
- Japan
- South Korea (Republic of Korea)
- Rest of APAC
This study identifies the government initiative in creating awareness about coronavirus as one of the prime reasons driving the coronavirus test kits market in APAC growth during the next few years.
The report on coronavirus test kits market in APAC covers the following areas:
- Coronavirus test kits market in APAC sizing
- Coronavirus test kits market in APAC forecast
- Coronavirus test kits market in APAC industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in APAC vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co Diagnostics Inc., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, and Thermo Fisher Scientific Inc. Also, the coronavirus test kits market in APAC analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Drivers Challenges and Trends
Vendor Landscape
Vendor Analysis
Appendix
Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the coronavirus test kits market in APAC: 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, BGI Genomics Co. Ltd., Co Diagnostics Inc., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Maccura Biotechnology Co. Ltd., Mylab Discovery Solutions Pvt Ltd., QIAGEN NV, and Thermo Fisher Scientific Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is the government initiative in creating awareness about coronavirus.'
According to the report, one of the major drivers for this market is the increasing incidence of coronavirus.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- 3D Biomedicine Science and Technology Co. Ltd.
- Abbott Laboratories
- BGI Genomics Co. Ltd.
- Co Diagnostics Inc.
- F. Hoffmann La Roche Ltd.
- Guangzhou Wondfo Biotech Co. Ltd.
- Maccura Biotechnology Co. Ltd.
- Mylab Discovery Solutions Pvt Ltd.
- QIAGEN NV
- Thermo Fisher Scientific Inc.
